A total of 281 adult patients ( 18-75 years ) with a mild-to-moderate primary hypertension diagnosis were randomly assigned , in a 1:1 ratio , to lercanidipine hydrochloride ( n = 139 ; 81 males ) or felodipine sustained-release tablets ( n = 142 ; 87 males ) .